Patents by Inventor Daphne E. Kelly

Daphne E. Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation of cyclohexene carboxylate derivatives
    Patent number: 6518438
    Abstract: The present invention provides new synthetic methods and compositions. In particular, new methods of preparing intermediates useful in the synthesis of neuraminidase inhibitors and compositions useful as intermediates that are themselves useful in the synthesis of neuraminidase inhibitors are provided.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: February 11, 2003
    Assignee: Gilead Sciences, Inc.
    Inventors: Kenneth M. Kent, Choung U. Kim, Lawrence R. McGee, John D. Munger, Ernest J. Prisbe, Michael J. Postich, John C. Rohloff, Daphne E. Kelly, Matthew A. Williams, Lijun Zhang
  • Preparation of cyclohexene carboxylate derivatives
    Publication number: 20020156300
    Abstract: The present invention provides new synthetic methods and compositions. In particular, new methods of preparing intermediates useful in the synthesis of neuraminidase inhibitors and compositions useful as intermediates that are themselves useful in the synthesis of neuraminidase inhibitors are provided.
    Type: Application
    Filed: September 27, 2001
    Publication date: October 24, 2002
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Kenneth M. Kent, Choung U. Kim, Lawrence R. McGee, John D. Munger, Ernest J. Prisbe, Michael J. Postich, John C. Rohloff, Daphne E. Kelly, Matthew A. Williams, Lijun Zhang
  • Nucleotide analog compositions
    Patent number: 6451340
    Abstract: The invention provides crystalline forms of adefovir dipivoxil and methods to prepare the crystals. The compositions and methods of the present invention have desirable properties for large scale synthesis of crystalline adefovir dipivoxil or for its formulation into therapeutic dosages. Invention compositions include an anhydrous crystal form of adefovir dipivoxil.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: September 17, 2002
    Assignee: Gilead Sciences, Inc.
    Inventors: Murty N. Arimilli, Daphne E. Kelly, Thomas T. K. Lee, Lawrence V. Manes, John D. Munger, Jr., Ernest J. Prisbe, Lisa M. Schultze
  • Preparation of cyclohexene carboxylate derivatives
    Publication number: 20020058823
    Abstract: The present invention provides new synthetic methods and compositions. In particular, new methods of preparing intermediates useful in the synthesis of neuraminidase inhibitors and compositions useful as intermediates that are themselves useful in the synthesis of neuraminidase inhibitors are provided.
    Type: Application
    Filed: December 19, 2000
    Publication date: May 16, 2002
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Kenneth M. Kent, Choung U. Kim, Lawrence R. McGee, John D. Munger, Ernest J. Prisbe, Michael J. Postich, John C. Rohloff, Daphne E. Kelly, Matthew A. Williams, Lijun Zhang
  • Nucleotide analog compositions
    Publication number: 20020045599
    Abstract: The invention provides crystalline forms of adefovir dipivoxil and methods to prepare the crystals. The compositions and methods of the present invention have desirable properties for large scale synthesis of crystalline adefovir dipivoxil or for its formulation into therapeutic dosages. Invention compositions include an anhydrous crystal form of adefovir dipivoxil.
    Type: Application
    Filed: September 10, 2001
    Publication date: April 18, 2002
    Applicant: Gilead Sciences, Inc.
    Inventors: Murty N. Arimilli, Daphne E. Kelly, Thomas T.K. Lee, Lawrence V. Manes, John D. Munger, Ernest J. Prisbe, Lisa M. Schultze
  • Preparation of cyclohexene carboxylate derivatives
    Patent number: 6204398
    Abstract: The present invention provides new synthetic methods and compositions. In particular, new methods of preparing intermediates such as those having formulas (I)-(IV), useful in the synthesis of neuraminidase inhibitors and compositions useful as intermediates that are themselves useful in the synthesis of neuraminidase inhibitors are provided.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: March 20, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Kenneth M. Kent, Choung U. Kim, Lawrence R. McGee, John D. Munger, Ernest J. Prisbe, Michael J. Postich, John C. Rohloff, Daphne E. Kelly, Matthew A. Williams, Lijun Zhang
  • Preparation of carbocyclic compounds
    Patent number: 5886213
    Abstract: The present invention provides new synthetic methods and compositions. In particular, new methods of preparing intermediates useful in the synthesis of neuraminidase inhibitors and compositions useful as intermediates that are themselves useful in the synthesis of neuraminidase inhibitors are provided.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: March 23, 1999
    Assignee: Gilead Sciences, Inc.
    Inventors: Kenneth M. Kent, Choung U. Kim, Lawrence R. McGee, John D. Munger, Ernest J. Prisbe, Michael J. Postich, John C. Rohloff, Daphne E. Kelly, Matthew A. Williams, Lijun Zhang